An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Ekso Bionics, a leader in exoskeleton technology for medical and industrial use, will report its first quarter 2024 financial results on April 29, 2024. The Company will discuss financial results and recent business developments in a conference call.
Ekso Bionics, leader nella tecnologia degli esoscheletri per uso medico e industriale, comunicherà i risultati finanziari del primo trimestre del 2024 il 29 aprile 2024. La società discuterà i risultati finanziari e gli sviluppi recenti del business durante una conferenza telefonica.
Ekso Bionics, líder en tecnología de exoesqueletos para uso médico e industrial, informará los resultados financieros del primer trimestre de 2024 el 29 de abril de 2024. La compañía discutirá los resultados financieros y los recientes desarrollos empresariales en una llamada de conferencia.
의료 및 산업용 외골격 기술의 선두주자인 엑소 바이오닉스는 2024년 4월 29일에 2024년 첫 분기 재무 결과를 보고할 예정입니다. 회사는 컨퍼런스 콜에서 재무 결과와 최근 비즈니스 개발에 대해 논의할 것입니다.
Ekso Bionics, leader de la technologie des exosquelettes pour une utilisation médicale et industrielle, publiera ses résultats financiers du premier trimestre 2024 le 29 avril 2024. La société discutera des résultats financiers et des développements commerciaux récents lors d'une conférence téléphonique.
Ekso Bionics, ein führendes Unternehmen in der Exoskelett-Technologie für medizinischen und industriellen Einsatz, wird seine Finanzergebnisse für das erste Quartal 2024 am 29. April 2024 bekannt geben. Das Unternehmen wird in einem Telefonkonferenz die Finanzergebnisse und jüngsten Geschäftsentwicklungen besprechen.
Positive
None.
Negative
None.
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2024 after the close of trading on Monday, April 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers.
A webcast replay will also be available on the Company’s website for one month following the completion of the call.
About Ekso Bionics® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.
Contact: David Carey 212-867-1768 investors@eksobionics.com
FAQ
When will Ekso Bionics report its first quarter 2024 financial results?
Ekso Bionics will report its first quarter 2024 financial results on April 29, 2024.
What is Ekso Bionics' ticker symbol?
Ekso Bionics' ticker symbol is EKSO.
Where can investors listen to the conference call discussing Ekso Bionics' financial results?
Investors can listen to the conference call by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers. A webcast replay will also be available on the Company's website.
since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774
